NextCure (NXTC) Short Interest Ratio & Short Volume $1.41 -0.13 (-8.44%) (As of 11/13/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NextCure Short Interest DataNextCure (NXTC) has a short interest of 66,100 shares, representing 0.31% of the float (the number of shares available for trading by the public). This marks a -10.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 122,792 shares to cover all short positions.Current Short Interest66,100 sharesPrevious Short Interest73,800 sharesChange Vs. Previous Month-10.43%Dollar Volume Sold Short$87,582.50Short Interest Ratio2.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares28,010,000 sharesFloat Size21,310,000 sharesShort Percent of Float0.31%Today's Trading Volume32,879 sharesAverage Trading Volume122,792 sharesToday's Volume Vs. Average27% Short Selling NextCure? Sign up to receive the latest short interest report for NextCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNXTC Short Interest Over TimeNXTC Days to Cover Over TimeNXTC Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth NextCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202466,100 shares $87,582.50 -10.4%0.3%2.1 $1.33 10/15/202473,800 shares $103,320.00 -3.0%0.4%2.3 $1.40 9/30/202476,100 shares $104,257.00 +15.7%0.4%2.1 $1.37 9/15/202465,800 shares $92,120.00 -15.4%0.3%1.5 $1.40 8/31/202477,800 shares $114,366.00 -2.9%0.4%1.6 $1.47 8/15/202480,100 shares $124,956.00 -7.0%0.4%1.4 $1.56 Get the Latest News and Ratings for NXTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NextCure and its competitors with MarketBeat's FREE daily newsletter. 7/31/202486,100 shares $139,482.00 +2.4%0.4%1.2 $1.62 7/15/202484,100 shares $140,447.00 -15.0%0.4%0.9 $1.67 6/30/202498,900 shares $157,251.00 +41.1%0.5%1 $1.59 6/15/202470,100 shares $112,160.00 -19.4%0.3%0.5 $1.60 5/31/202487,000 shares $133,980.00 -3.9%0.4%0.4 $1.54 5/15/202490,500 shares $150,230.00 -19.5%0.4%0.3 $1.66 4/30/2024112,400 shares $136,004.00 -0.7%0.5%0.4 $1.21 4/15/2024113,200 shares $189,044.00 -88.6%0.5%0.4 $1.67 3/31/2024993,800 shares $2.22 million +18.4%4.7%3.8 $2.23 3/15/2024839,700 shares $1.22 million +579.9%4.0%3.7 $1.45 2/29/2024123,500 shares $213,655.00 +4.7%0.6%0.7 $1.73 2/15/2024118,000 shares $166,380.00 +8.4%0.6%1.1 $1.41 1/31/2024108,900 shares $132,858.00 -11.8%0.6%1.2 $1.22 1/15/2024123,400 shares $143,144.00 -42.8%0.6%1.3 $1.16 12/31/2023215,800 shares $246,012.00 -6.2%1.1%2.2 $1.14 12/15/2023230,000 shares $255,300.00 +17.3%1.2%2.3 $1.11 11/30/2023196,100 shares $231,398.00 -0.6%1.0%3.2 $1.18 11/15/2023197,200 shares $246,500.00 +0.1%1.0%3.7 $1.25 10/31/2023197,000 shares $202,910.00 -1.5%1.0%3.7 $1.03 10/15/2023199,900 shares $249,875.00 -13.2%1.0%4.7 $1.25 9/30/2023230,300 shares $297,087.00 +11.9%1.2%6.4 $1.29 9/15/2023205,900 shares $284,142.00 -2.5%1.1%4.8 $1.38 8/31/2023211,100 shares $308,206.00 +0.3%1.1%5.2 $1.46 8/15/2023210,500 shares $357,850.00 -1.5%1.1%4.8 $1.70 7/31/2023213,800 shares $367,736.00 -3.5%1.1%4.2 $1.72 7/15/2023221,600 shares $390,016.00 -17.9%1.1%4.1 $1.76 6/30/2023269,800 shares $485,640.00 +7.2%1.4%4.7 $1.80 6/15/2023251,700 shares $420,339.00 +6.6%1.3%4.7 $1.67 5/31/2023236,100 shares $406,092.00 -12.2%1.2%3.9 $1.72 5/15/2023268,900 shares $457,856.03 +4.3%1.4%3.8 $1.70 4/30/2023257,800 shares $389,278.00 -4.1%1.3%3.4 $1.51 4/15/2023268,700 shares $403,050.00 -15.4%1.4%3.2 $1.50 3/31/2023317,700 shares $470,196.00 -3.8%1.6%3.5 $1.48 3/15/2023330,300 shares $518,571.00 -6.9%1.7%2.1 $1.57Top "Sleeping Giant" Crypto In The Market Now (Ad)Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late 2/28/2023354,900 shares $550,095.00 +14.7%1.8%2.1 $1.55 2/15/2023309,500 shares $485,915.00 -7.3%1.6%1.7 $1.57 1/31/2023333,900 shares $557,613.00 -0.2%1.9%1.7 $1.67 1/15/2023334,700 shares $538,867.00 -9.5%1.9%1.7 $1.61 12/30/2022369,800 shares $521,418.00 -12.5%2.1%1.9 $1.41 12/15/2022422,600 shares $549,380.00 +3.4%2.4%2.5 $1.30 11/30/2022408,600 shares $576,126.00 -4.3%2.3%3.5 $1.41 11/15/2022426,800 shares $708,488.00 -10.2%2.4%4 $1.66 10/31/2022475,300 shares $1.19 million -11.6%2.7%4.1 $2.50 10/15/2022537,400 shares $1.45 million -8.6%3.3%5.4 $2.70 9/30/2022587,800 shares $1.62 million -3.2%3.6%5.5 $2.75 9/15/2022607,100 shares $2.31 million -21.6%3.7%4.8 $3.81 8/31/2022774,000 shares $3.17 million -2.9%4.7%5.2 $4.10 8/15/2022797,000 shares $4.14 million +9.9%4.8%4.5 $5.19 7/31/2022725,100 shares $3.12 million -9.4%4.4%4.1 $4.30 7/15/2022800,000 shares $3.66 million -4.9%4.9%4.6 $4.57 6/30/2022841,200 shares $3.95 million +13.1%5.1%5 $4.70 6/15/2022743,900 shares $3.37 million +21.4%4.5%4.5 $4.53 5/31/2022612,700 shares $2.39 million -4.0%3.7%4.3 $3.90 5/15/2022638,500 shares $2.26 million +1.5%3.9%5.4 $3.54 4/30/2022629,300 shares $2.62 million +0.4%3.8%5.7 $4.16 4/15/2022626,800 shares $3.14 million +2.9%3.8%4.9 $5.01 3/31/2022608,900 shares $2.96 million -5.8%3.7%4.5 $4.86 3/15/2022646,200 shares $3.15 million +2.1%N/A4.4 $4.88 2/28/2022633,000 shares $3.10 million -7.6%3.8%3.8 $4.90 2/15/2022685,100 shares $3.59 million -10.1%4.1%3.7 $5.24 1/31/2022761,900 shares $4.24 million -1.0%4.7%3.2 $5.57 1/15/2022769,700 shares $4.37 million +0.7%4.8%3 $5.68 12/31/2021764,600 shares $4.59 million +11.0%4.8%2.9 $6.00 12/15/2021688,900 shares $4.02 million +3.6%4.3%2.3 $5.83 11/30/2021664,800 shares $4.16 million +16.4%4.1%2.3 $6.25 11/15/2021571,000 shares $3.53 million -6.3%3.6%2.1 $6.18 10/29/2021609,100 shares $5.01 million -8.4%3.9%2.3 $8.22 10/15/2021665,200 shares $5.81 million -15.2%4.3%2.7 $8.73 9/30/2021784,700 shares $5.29 million -4.9%5.1%3.4 $6.74 9/15/2021825,300 shares $6.01 million +4.3%5.3%3.3 $7.28 8/31/2021791,300 shares $6.03 million -15.4%5.1%3.1 $7.62 8/13/2021934,800 shares $6.74 million +0.7%6.0%3.3 $7.21 7/30/2021928,000 shares $6.43 million -9.9%6.0%3.4 $6.93 7/15/20211,030,000 shares $7.42 million +49.8%5.7%3.7 $7.20 6/30/2021687,800 shares $5.52 million -37.5%3.8%2.4 $8.03 6/15/20211,100,000 shares $8.95 million +0.9%6.0%4.6 $8.14 5/28/20211,090,000 shares $8.56 million +5.8%6.0%4.9 $7.85 5/14/20211,030,000 shares $8.25 million -1.0%5.7%4.8 $8.01 4/30/20211,040,000 shares $9.45 million -29.3%5.7%4.6 $9.09 4/15/20211,470,000 shares $13.88 million +1.4%8.1%6.9 $9.44 3/31/20211,450,000 shares $14.22 million -5.2%8.0%6.7 $9.81 3/15/20211,530,000 shares $19.39 million -3.2%8.4%5.5 $12.67 2/26/20211,580,000 shares $18.26 million -18.6%8.7%4.6 $11.56 2/12/20211,940,000 shares $26.93 million +5.4%10.7%5.3 $13.88Top "Sleeping Giant" Crypto In The Market Now (Ad)Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late 1/29/20211,840,000 shares $22.41 million +155.3%10.1%4.8 $12.18 1/15/2021720,800 shares $9.42 million -22.1%4.2%1.8 $13.07 12/31/2020925,100 shares $10.27 million -17.4%5.3%2.4 $11.10 12/15/20201,120,000 shares $13.78 million -32.1%6.5%2.6 $12.30 11/30/20201,650,000 shares $17.13 million +50.0%9.6%4.4 $10.38 11/15/20201,100,000 shares $11.61 million -42.1%6.4%2.9 $10.55 10/30/20201,900,000 shares $19.78 million +6.7%11.1%4.7 $10.41 10/15/20201,780,000 shares $20.74 million -9.6%11.0%3.3 $11.65 9/30/20201,970,000 shares $17.34 million -1.0%N/A2.3 $8.80 9/15/20201,990,000 shares $18.23 million +1.0%12.2%2.3 $9.16 8/31/20201,970,000 shares $17.71 million +8.8%12.1%2.3 $8.99 8/14/20201,810,000 shares $16.51 million -19.2%11.2%2.1 $9.12 7/31/20202,240,000 shares $19.98 million +8.7%13.8%2.8 $8.92 7/15/20202,060,000 shares $18.70 million -2.8%12.7%3.1 $9.08 6/30/20202,120,000 shares $47.04 million +21.8%13.1%5.9 $22.19 6/15/20201,740,000 shares $42.49 million +41.5%10.7%5.8 $24.42 5/29/20201,230,000 shares $38.39 million +2.5%7.6%4.5 $31.21 5/15/20201,200,000 shares $42.58 million -4.8%7.4%5.2 $35.48 4/30/20201,260,000 shares $46.24 million +7.7%7.9%5.6 $36.70 4/15/20201,170,000 shares $40.81 million +0.9%7.3%5 $34.88 3/31/20201,160,000 shares $42.35 million -10.5%7.2%5 $36.51 3/13/20201,296,200 shares $52.11 million +11.7%8.1%5.8 $40.20 2/28/20201,160,000 shares $37.49 million +3.6%7.3%4.2 $32.32 2/14/20201,120,000 shares $46.12 million -8.2%7.0%3.3 $41.18 1/31/20201,220,000 shares $54.31 million +6.1%7.6%2.7 $44.52 1/15/20201,150,000 shares $53.43 million +10.6%6.4%2 $46.46 12/31/20191,040,000 shares $46.29 million +120.1%9.2%1.8 $44.51 NXTC Short Interest - Frequently Asked Questions What is NextCure's current short interest? Short interest is the volume of NextCure shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 66,100 shares of NXTC short. 0.31% of NextCure's shares are currently sold short. Learn More on NextCure's current short interest. What is a good short interest ratio for NextCure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NXTC shares currently have a short interest ratio of 2.0. Learn More on NextCure's short interest ratio. What is a good short interest percentage for NextCure? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.31% of NextCure's floating shares are currently sold short. Is NextCure's short interest increasing or decreasing? NextCure saw a drop in short interest in October. As of October 31st, there was short interest totaling 66,100 shares, a drop of 10.4% from the previous total of 73,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NextCure's float size? NextCure currently has issued a total of 28,010,000 shares. Some of NextCure's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NextCure currently has a public float of 21,310,000 shares. How does NextCure's short interest compare to its competitors? 0.31% of NextCure's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NextCure: Hookipa Pharma Inc (0.47%), Kezar Life Sciences, Inc. (2.87%), LifeVantage Co. (2.58%), Adverum Biotechnologies, Inc. (13.39%), Skye Bioscience, Inc. (8.88%), Acumen Pharmaceuticals, Inc. (3.22%), Puma Biotechnology, Inc. (9.07%), Checkpoint Therapeutics, Inc. (14.88%), FitLife Brands, Inc. (0.19%), Innate Pharma S.A. (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short NextCure stock? Short selling NXTC is an investing strategy that aims to generate trading profit from NextCure as its price is falling. NXTC shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NextCure? A short squeeze for NextCure occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NXTC, which in turn drives the price of the stock up even further. How often is NextCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXTC, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Hookipa Pharma Short Interest Data Kezar Life Sciences Short Interest Data LifeVantage Short Interest Data Adverum Biotechnologies Short Interest Data Skye Bioscience Short Interest Data Acumen Pharmaceuticals Short Interest Data Puma Biotechnology Short Interest Data Checkpoint Therapeutics Short Interest Data FitLife Brands Short Interest Data Innate Pharma Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NXTC) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NextCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NextCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
